Negative methylation status of Vimentin predicts improved prognosis in pancreatic carcinoma

Table 2 Univariate analysis of overall survival in pancreatic carcinoma

Variables	n	Median survival (mo)	P value
Sex			0.819
Male	42	13.45
Female	22	10.84
Preoperative CEA			0.260
Normal	33	15.15
Elevated	31	13.61
Preoperative CA19-9			0.947
Normal	40	14.12
Elevated	24	15.09
Tumor position			0.007
Body and tail	40	16.20
Head	24	11.25
Pathological T stage			< 0.001
T1	19	21.01
T2	30	13.10
T3	15	8.00
Pathological N stage			0.311
N0	34	14.28
N1	30	16.20
Adjuvant chemotherapy
Yes	33	16.12	0.015
No	31	13.07
Vimentin methylation state			0.013
Positive	21	11.09
Negative	43	16.03